Last $161.44 USD
Change Today -0.12 / -0.07%
Volume 3.1M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin MacKay Ph.D.

Global Head of Research & Development and Executive Vice President , Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

57$6,261,862
As of Fiscal Year 2013

Background*

Dr. Martin Mackay has been Global Head of Research & Development and Executive Vice President at Alexion Pharmaceuticals, Inc. since May 2013. Dr. Mackay served as the President of R&D at AstraZeneca PLC from July 1, 2010 to January 31, 2013. Dr. Mackay led AstraZeneca's research and development organisation and had overall accountability for delivering new products - small molecules and biologics - from its pipeline. Dr. Mackay served as President of PharmaTherapeutics ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Former Director
2008-2008
Former Director

Education*

Honors Degree
Heriot-Watt University
PhD 1983
University of Edinburgh in Scotland

Other Affiliations*

Annual Compensation*

Salary$397,000
Bonus$150,000
Total Annual Compensation$547,000

Stock Options*

Restricted Stock Awards$2,621,500
All Other Compensation$7,212
Unexercisable Options100,000
Unexercisable Options Value$2,802,000
Total Value of Options$2,802,000
Total Number of Options100,000

Total Compensation*

Total Annual Cash Compensation$1,004,212
Total Short Term Compensation$547,000
Other Long Term Compensation$2,628,712
Total Calculated Compensation$6,261,862
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $161.44 USD -0.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
$1.1M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.